Allergies respitatory
Drug research and approvals for allergies respitatory: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 0 studies of allergies respitatory are recruiting on ClinicalTrials.gov, and Health Canada has authorized 12 drug trials for it since 2013.
- Recruiting worldwide: 0
- Trials authorized in Canada: 12
- FDA orphan approvals: 0
- EU medicines: 0
The 10 newest of 12; search them all in Canada trials
| Jul 31, 2015 | A single-centre, randomized, double blind, placebo-controlled, parallel group study to investigate the relative efficacy and safety of immunotherapy with…Sublivac fix phleum pratense | Hal Allergy BV | Ongoing |
| Jul 3, 2015 | A double-blind, randomised, placebo-controlled, escalating, multiple dose study in birch-allergic subjects to assess the asfety, tolerability and…Birch-spire | Circassia Pharmaceuticals | Ongoing |
| Dec 10, 2014 | A pilot study to compare responses to cat allergen exposure using the environmental exposure chamber (EEC) and nasal allergen challenge (NAC)Cat dander | National Institute of Health | Closed |
| Nov 13, 2014 | The effect of peptide immunotherapy on frequency, memory phenotype, chemokine receptor expression and markers of regulatory t cell function allergan-specific t…Cat-pad | National Institute of Health | Closed |
| Mar 28, 2014 | A multi-centre, double-blind, randomised, placebo-controlled parallel-group study to assess the safety and tolerability of grass-spire in subjects with asthma…Grass-spire (toleromune grass) | Circassia Pharmaceuticals | Ongoing |
| Nov 22, 2013 | Inhaled allergen challengeAllergen extract for inhalation (cat hair) | McMaster University | Pending |
| Nov 22, 2013 | Segmental allergen challengeAllergen extracts for inhalation (cat pelt), Allergen extracts for inhalation… | McMaster University | Pending |
| Nov 15, 2013 | A single group study evaluating reproducibility of rhinitis symptoms induced by allergen exposure in the red maple trials allergen challenge theatre (ACT) in…Greer timothy grass pollen | Red Maple Trials Inc | Ongoing |
| Sep 24, 2013 | "an optional investigation of biomarkers of efficacy in TH002 clinical study subjects."Toleromune house dust mite | Circassia Pharmaceuticals | Pending |
| Sep 19, 2013 | "a mutli-centre, double-blind, randomised, placebo-controlled parallel-group study to assess the tolerability of tolermune house dust mite in subjects with…Tolermune house dust mite | Circassia Pharmaceuticals | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA